Oil Is the New Gold
Health Care: Drugs
Neostem Inc. (NBS: AMEX)
$0.53 -0.01 | -2.23%
06/19/13 - 03:59 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 134,102 | 935,405 | 942,676 | 838,799 | 12,017 | 58,935 | 232,776 |
| Shares Bought | 134,102 | 935,405 | 942,676 | 838,799 | 78,017 | 124,935 | 298,776 |
| Shares Sold | 0 | 0 | 0 | 0 | 66,000 | 66,000 | 66,000 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 9.47M | 9.31M | 9.55M | 9.35M | 9.35M | 9.51M | 15.55M |
| Shares Bought | 814,046 | 654,046 | 623,558 | 422,589 | 422,589 | 483,436 | 8.38M |
| Shares Sold | 6.07M | 6.07M | 6.54M | 6.54M | 6.54M | 6.53M | 1.25M |
Portfolios with NBS
- Portfolio NameUser Type
- Usermine
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserChris
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
Latest NBS Headlines from TheStreet
- NeoStem Announces Geographic Expansion Of Intellectual Property Coverage Of AMR-001 To Canada 06.17.13 | 08:06 am
- NeoStem's Subsidiary, PCT, Enters Into A Manufacturing Agreement With ImmunoCellular Therapeutics, Ltd. For Dendritic Cell Vaccines Targeting Brain And Other Cancers 06.03.13 | 07:06 am
- NeoStem Announces Presentations At 2nd Baltic Stem Cell Meeting And Session To Feature VSEL(TM) Technology 05.30.13 | 07:05 am
- NeoStem Announces Geographic Expansion Of Intellectual Property Coverage Of Cardiovascular Asset AMR-001 05.16.13 | 07:05 am
- NeoStem To Present At Multiple Conferences In May 05.14.13 | 07:05 am
- NeoStem's Subsidiary, Progenitor Cell Therapy, To Provide Autologous And Allogeneic Cellular Therapy Services To MedStar Georgetown University Hospital 05.13.13 | 07:05 am
- NeoStem Clarification: No New Securities Being Issued 05.09.13 | 07:05 pm
- NeoStem CEO's Letter To Shareholders 05.09.13 | 04:05 pm
- NeoStem Announces Closing Of Public Offering Of Common Stock 05.03.13 | 08:05 am
- NeoStem Announces Partial Exercise Of Underwriters' Over-Allotment Option 04.30.13 | 06:04 pm
Press Releases for NBS
- Faruqi & Faruqi, LLP Launches Investigation Against NeoStem, Inc. (NBS) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors In The Manner It Seeks Executive Compensation Approval - Business Wire 09.18.12 | 04:09 pm
- Donald Trump, Jr. Headlines As Special Speaker At The WallStreet Research⢠Small Cap Conference VII, Being Held At The Penn Club (Affiliated With The Wharton School Of Finance) On November 15th - PR Newswire 11.15.11 | 07:11 am
- NeoStem Acquires Amorcyte, A Clinical Stage Cardiovascular Disease Cell Therapy Company - PR Newswire 10.17.11 | 09:10 am
- NeoStem Announces Participation In Multiple October Conferences - PR Newswire 10.04.11 | 08:10 am
- NeoStem's Subsidiary, Progenitor Cell Therapy, And ImmunoCellular Therapeutics Enter Into A Manufacturing Agreement - PR Newswire 10.03.11 | 08:10 am
- NeoStem Announces Participation In Multiple September Conferences - PR Newswire 09.08.11 | 05:09 pm
- NeoStem Announces The Receipt Of Over $1,700,000 In DOD Funding For Its VSEL⢠Technology Being Developed To Treat Osteoporosis - PR Newswire 08.08.11 | 09:08 am
- NeoStem Subsidiary, Progenitor Cell Therapy, Announces Extension Of Manufacturing Agreements With Two Existing Clients - PR Newswire 07.18.11 | 09:07 am
- NeoStem Announces The Addition Of Joseph Talamo As Vice President, Corporate Controller And Chief Accounting Officer - PR Newswire 06.30.11 | 09:06 am
- The Pontifical Council For Culture And NeoStem Announce Steps Forward In Their Partnership To Advance Adult Stem Cell Research - PR Newswire 06.16.11 | 07:06 am
Partner Headlines for NBS
- Gain An Innovation, Strategic Edge With Partnerships - Investor's Business Daily 04.09.13 | 02:04 pm
- Cell Therapy Leader Stephen Potter Talks Osiris, NeoStem And The Industry Itself - Seeking Alpha 03.19.13 | 09:03 am
- 3 Regenerative Medicine Companies That Could Deliver In 2013 - Seeking Alpha 01.22.13 | 09:01 am
- Neuralstem Swinging For The ALS Fences - Seeking Alpha 10.29.12 | 09:10 am
- Forex Flash: Sheding some light on China/HSBC PMI differences - Markit - NASDAQ 09.03.12 | 12:09 am
- Cell Therapy Outlook Starting To Match Clinical Results - Seeking Alpha 08.21.12 | 09:08 am
- Reassessing & Continuing To Monitor Portfolios For Success - Seeking Alpha 07.30.12 | 09:07 am
- Baxter And Neostem Validating Each Other's Cell Therapies - Seeking Alpha 06.01.12 | 09:06 am
- Rodman & Renshaw Reiterates NeoStem Market Outperform, $3 PT - Benzinga 07.20.11 | 01:07 pm
- Morning Market Losers - Benzinga 07.19.11 | 09:07 am
